Parcourir l'index des titres "Antiplatelet therapy for atherothrombotic disease in 2022 : from population to patient-centered approaches"
Voici les éléments 1-1 de 1
-
Antiplatelet therapy for atherothrombotic disease in 2022 : from population to patient-centered approaches
(Frontiers Media, 2022-01-28)Antiplatelet agents, with aspirin and P2Y12 receptor antagonists as major key molecules, are currently the cornerstone of pharmacological treatment of atherothrombotic events including a variety of cardio- and cerebro-vascular as well as peripheral ...